Adam Cotton

Dr. Adam Cotton is an Analyst at the Novartis Venture Fund in Cambridge, MA, USA. Prior to joining NVF, he worked in the labs of Jim Wells and Ian Seiple, focusing on antibody engineering research. During his Ph.D. he worked as a technology analyst at UCSF Innovation Ventures focusing on patentability and commercial viability of UCSF inventions and in RA Capital’s company creation incubator. Through his own research and external projects, he has helped build three companies (co-founder of one) across different stages, modalities, and indications. Adam holds a B.A. in Chemistry from Harvard University, an M.B.A. from the University of New Mexico, and a Ph.D. in Chemistry and Chemical Biology from the University of California, San Francisco.